Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas